Paper357745
Angiogenesis and oncogenesis.
Gullino PM. J Natl Cancer Inst, 1978. Cited by 94 papers, by iCite.
Cite this record
ConductScience Library. Angiogenesis and oncogenesis. Papers, record 357745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/357745
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiogenesis Inducing Agents | Major topic |
| Growth Substances | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Breast Neoplasms | |
| Cell Transformation, Neoplastic | |
| Female | |
| Humans | |
| Male | |
| Mammary Neoplasms, Experimental | |
| Precancerous Conditions |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34552183 | The development of tumour vascular networks. | Commun Biol | 2021 | https://conductscience.org/library/papers/34552183 | PubMed |
| 31966483 | CCL4 promotes the cell proliferation, invasion and migration of endometrial carcinoma by targeting the VEGF-A signal pathway. | Int J Clin Exp Pathol | 2017 | https://conductscience.org/library/papers/31966483 | PubMed |
| 27823583 | Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation. | Elife | 2016 | https://conductscience.org/library/papers/27823583 | PubMed |
| 26918726 | Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors. | Oncotarget | 2016 | https://conductscience.org/library/papers/26918726 | PubMed |
| 26456697 | Novel anticancer agent, SQAP, binds to focal adhesion kinase and modulates its activity. | Sci Rep | 2015 | https://conductscience.org/library/papers/26456697 | PubMed |
| 26000022 | Combined effects of pericytes in the tumor microenvironment. | Stem Cells Int | 2015 | https://conductscience.org/library/papers/26000022 | PubMed |
| 25363007 | Antiangiogenic therapies for glioblastoma. | CNS Oncol | 2014 | https://conductscience.org/library/papers/25363007 | PubMed |
| 24740542 | Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth. | Am J Physiol Cell Physiol | 2014 | https://conductscience.org/library/papers/24740542 | PubMed |
| 24263574 | Trace element inhibition of carcinogenesis and angiogenesis. | Biol Trace Elem Res | 1983 | https://conductscience.org/library/papers/24263574 | PubMed |
| 22720169 | The Roles of Angiogenesis in Malignant Melanoma: Trends in Basic Science Research over the Last 100 Years. | ISRN Oncol | 2012 | https://conductscience.org/library/papers/22720169 | PubMed |
| 21742796 | Normalization of the vasculature for treatment of cancer and other diseases. | Physiol Rev | 2011 | https://conductscience.org/library/papers/21742796 | PubMed |
| 16870537 | Inhibitors of angiogenesis. | Clin Transl Oncol | 2006 | https://conductscience.org/library/papers/16870537 | PubMed |
| 11964252 | Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions affects protein folding. | Biophys J | 2002 | https://conductscience.org/library/papers/11964252 | PubMed |
| 11381144 | Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11381144 | PubMed |
| 10935474 | Causes and effects of heterogeneous perfusion in tumors. | Neoplasia | 1999 | https://conductscience.org/library/papers/10935474 | PubMed |
| 9675169 | Nature of interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(Carbonyl-bis[imino-N-methyl-4, 2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino] )bis-(1, 3-naphthalene disulfonate). | Biophys J | 1998 | https://conductscience.org/library/papers/9675169 | PubMed |
| 7781141 | Antitumor activity of FCE 26644 a new growth-factor complexing molecule. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7781141 | PubMed |
| 7582244 | A quantitative investigation of immunocytochemically stained blood vessels in normal, benign, premalignant and malignant human oral cheek epithelium. | Virchows Arch | 1995 | https://conductscience.org/library/papers/7582244 | PubMed |
| 6388825 | Invasiveness of transformed bladder epithelial cells. | Cancer Metastasis Rev | 1984 | https://conductscience.org/library/papers/6388825 | PubMed |
| 6370420 | Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis. | Cancer Metastasis Rev | 1984 | https://conductscience.org/library/papers/6370420 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/357745
GET https://conductscience.org/api/papers/v1/357745/cited_by?page=2